Research programme: DNA helicase inhibitors - Beactica
Alternative Names: Werner syndrome helicase inhibitors - Beactica; WRN inhibitors - BeacticaLatest Information Update: 18 Jan 2021
At a glance
- Originator Beactica
- Developer Beactica; University of Dundee
- Class Antineoplastics
- Mechanism of Action DNA helicase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer